The Phytochemical Gamma-Fagarine from the Root of Zanthoxylum Bungeanum is an Effective Antiviral Against HMPV

Thailand HMPV News: A New Hope Against a Persistent Respiratory Threat
Human metapneumovirus (HMPV) is a common yet dangerous respiratory pathogen that affects individuals of all ages worldwide. Particularly severe in young children, the elderly, and immunocompromised individuals, HMPV has been linked to conditions ranging from mild respiratory symptoms to severe bronchiolitis and pneumonia. Despite its significant health impact, there are currently no vaccines or licensed antiviral drugs specifically targeting HMPV. This glaring medical gap has driven researchers to explore alternative therapeutic solutions, one of which may lie in the roots of a medicinal plant: Zanthoxylum bungeanum.


The Phytochemical Gamma-Fagarine from the Root of Zanthoxylum Bungeanum is an Effective
Antiviral Against HMPV

A collaborative team of Chinese researchers from Sichuan University’s West China School of Pharmacy, the Chongqing Key Laboratory of Child Infection and Immunity at Chongqing Medical University, and the Sichuan Institute for Translational Chinese Medicine have identified a natural compound called gamma-fagarine. Derived from the root of Zanthoxylum bungeanum, a plant well-known in traditional Chinese medicine, gamma-fagarine has shown promise as a novel antiviral agent against HMPV.
 
Insights from the Study
This Thailand HMPV News report explores the groundbreaking study, which utilized both cell cultures and animal models to investigate gamma-fagarine’s antiviral properties. Gamma-fagarine is an alkaloid previously recognized for its therapeutic potential in treating cancer and inflammatory diseases. However, its effectiveness against respiratory viruses, particularly HMPV, was largely unexamined until now.
 
The researchers began by isolating gamma-fagarine and testing its effects on two types of cell models: Vero-E6 cells and human bronchial epithelial cells (16HBE).
 
The study demonstrated that gamma-fagarine significantly inhibited HMPV replication without causing toxicity to the host cells. Infected cells treated with gamma-fagarine showed a reduction in viral loads by 67% and 55% in Vero-E6 and 16HBE cells, respectively. These findings were supported by real-time PCR, Western blotting, and immunofluorescence assays.
 
Mechanistic studies revealed that gamma-fagarine’s antiviral action is twofold: it blocks viral binding to heparan sulfate proteoglycans (HSPGs) on cell surfaces and disrupts the acidic environment within lysosomes, which the virus relies upon for replication. By targeting these critical steps, gamma-fagarine effectively prevents the virus from attaching to and replicating within host cells.
 
Animal Studies Confirm Effectiveness
To further validate its therapeutic potential, the research team conducted experiments on a mouse model infected with HMPV. Mice treated with gamma-fagarine (administered orally at a dose of 25 mg/kg) exhibited significantly reduced viral loads in lung tissues compared to untreated controls. Additionally, the compound mitigated the severe pathological damage typically caused by HMPV infection, such as alveolar destruction and inflammatory infiltration.
 
Notably, the study found that gamma-fagarine outperformed ribavirin, a broad-spectrum antiviral that has shown limited efficacy against HMPV. While ribavirin’s effects diminished over time, gamma-fagarine maintained its antiviral activity, suggesting its potential as a more reliable treatment option.
 
The Mechanism Behind Gamma-Fagarine’s Success
Understanding the mechanism of action is critical for drug development, and gamma-fagarine’s dual-targeted approach is particularly noteworthy.
 
First, it prevents the virus from attaching to HSPGs, which are essential co-receptors that facilitate viral entry into host cells. By disrupting this interaction, gamma-fagarine significantly reduces the chances of infection.
 
Second, gamma-fagarine alters lysosomal pH levels, creating an unfavorable environment for the virus’s replication process. HMPV, like many respiratory viruses, relies on the acidic conditions within lysosomes to produce and release new viral particles. By neutralizing this environment, gamma-fagarine halts the virus’s lifecycle at a critical stage.
 
These dual mechanisms make gamma-fagarine a particularly promising candidate for further development, not just against HMPV but potentially against other respiratory viruses such as influenza and SARS-CoV-2.
 
Broader Implications for Antiviral Research
The implications of this discovery extend beyond HMPV. The study highlights the untapped potential of natural compounds in combating viral infections, particularly those derived from plants with a history of medicinal use.
 
Zanthoxylum bungeanum, often used as a spice and traditional remedy in China, exemplifies how traditional medicine can inspire modern pharmaceutical innovation.
 
Moreover, gamma-fagarine’s ability to target multiple stages of the viral lifecycle could inform the development of combination therapies, enhancing its effectiveness and reducing the likelihood of resistance.
 
Conclusion
The study conducted by researchers from Sichuan University, Chongqing Medical University, and the Sichuan Institute for Translational Chinese Medicine underscores the potential of gamma-fagarine as a groundbreaking antiviral agent. By inhibiting viral attachment and replication through its effects on HSPGs and lysosomal pH, gamma-fagarine demonstrates robust efficacy against HMPV in both in vitro and in vivo models.
 
The findings pave the way for further research into the clinical applications of gamma-fagarine, including its use in combination therapies or as a standalone treatment. Given its effectiveness and low toxicity, gamma-fagarine holds promise as a valuable addition to the arsenal against respiratory viruses, offering hope to millions affected by these infections.
 
The study findings were published in the peer-reviewed journal: Virus Research.
https://www.sciencedirect.com/science/article/pii/S0168170223001855
 
For the latest Thailand HMPV News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/columbia-university-study-finds-that-the-phytochemical-ginkgolic-acid-can-inhibit-human-metapneumovirus-infectivity
 
https://www.thailandmedical.news/news/hmpv-is-adapt-at-viral-persistence-hiding-in-lung-neural-fibers-and-reactivated-by-glucocorticoid-treatments
 
https://www.thailandmedical.news/news/emerging-novel-lineages-of-human-metapneumovirus-in-china-mark-the-start-of-2025
 
https://www.thailandmedical.news/news/human-metapneumovirus-infections-on-the-rise-in-china
 
https://www.thailandmedical.news/articles/hmpv-human-metapneumovirus